Literature DB >> 24980874

Phosphatidylethanolamine biomimetic coating increases mesenchymal stem cell osteoblastogenesis.

Bérengère J C Luthringer1, Uma M R Katha, Regine Willumeit.   

Abstract

Previous observations (e.g., decreased bacterial adhesion) have shed the light on the auspicious possibility to use phosphatidylethanolamine as biomimetic coating for metal implants. Additionally, it was experimentally shown that phosphatidylethanolamine induces bone formation, however, up to now no study was performed to understand this observation or to find an explanation. In an attempt to unveil how and why phosphatidylethanolamine can improve cell metabolism and osteogenic differentiation, primary cells (human umbilical cord perivascular cells) were cultured on native or phosphatidylethanolamine coated surfaces. Several parameters were followed on gene (real time polymerase chain reaction) and protein (e.g., dot-blot and ELISA tests) levels. It was determined that phosphatidylethanolamine potentiates cell metabolism, osteogenic differentiation, and mineralisation early processes. By preventing biofilm formation while promoting new bone formation, phosphatidylethanolamine could be easily implemented as implant bio-mimicking coating.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24980874     DOI: 10.1007/s10856-014-5263-8

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  56 in total

Review 1.  Divide, accumulate, differentiate: cell condensation in skeletal development revisited.

Authors:  B K Hall; T Miyake
Journal:  Int J Dev Biol       Date:  1995-12       Impact factor: 2.203

2.  Mechanical properties and the hierarchical structure of bone.

Authors:  J Y Rho; L Kuhn-Spearing; P Zioupos
Journal:  Med Eng Phys       Date:  1998-03       Impact factor: 2.242

3.  Bone type V collagen: chain composition and location of a trypsin cleavage site.

Authors:  C Niyibizi; D R Eyre
Journal:  Connect Tissue Res       Date:  1989       Impact factor: 3.417

4.  The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2.

Authors:  Hyun-Jung Kim; Jung-Hwan Kim; Suk-Chul Bae; Je-Yong Choi; Hyun-Jung Kim; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2002-10-25       Impact factor: 5.157

5.  Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis.

Authors:  Lilian H D van Tuyl; Alexandre E Voskuyl; Maarten Boers; Piet Geusens; Robert B M Landewé; Ben A C Dijkmans; Willem F Lems
Journal:  Ann Rheum Dis       Date:  2010-06-04       Impact factor: 19.103

6.  Involvement of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in osteoclastogenesis: a possible role in direct interaction between osteoclast precursors.

Authors:  H Harada; T Kukita; A Kukita; Y Iwamoto; T Iijima
Journal:  Endocrinology       Date:  1998-09       Impact factor: 4.736

7.  Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells.

Authors:  S E Gitelman; M Kirk; J Q Ye; E H Filvaroff; A J Kahn; R Derynck
Journal:  Cell Growth Differ       Date:  1995-07

Review 8.  Regulation of bone development and extracellular matrix protein genes by RUNX2.

Authors:  Toshihisa Komori
Journal:  Cell Tissue Res       Date:  2009-08-01       Impact factor: 5.249

9.  Phosphoethanolamine- and fructose 1,6-diphosphate-induced calcium uptake in bone formed in vitro.

Authors:  H C Tenenbaum; K Palangio
Journal:  Bone Miner       Date:  1987-05

10.  A twist code determines the onset of osteoblast differentiation.

Authors:  Peter Bialek; Britt Kern; Xiangli Yang; Marijke Schrock; Drazen Sosic; Nancy Hong; Hua Wu; Kai Yu; David M Ornitz; Eric N Olson; Monica J Justice; Gerard Karsenty
Journal:  Dev Cell       Date:  2004-03       Impact factor: 12.270

View more
  2 in total

1.  Endo- and Exometabolome Crosstalk in Mesenchymal Stem Cells Undergoing Osteogenic Differentiation.

Authors:  Daniela S C Bispo; Lenka Michálková; Marlene Correia; Catarina S H Jesus; Iola F Duarte; Brian J Goodfellow; Mariana B Oliveira; João F Mano; Ana M Gil
Journal:  Cells       Date:  2022-04-07       Impact factor: 7.666

2.  Engineering microdent structures of bone implant surfaces to enhance osteogenic activity in MSCs.

Authors:  Sophia Li; Thomas Chow; Julia Chu
Journal:  Biochem Biophys Rep       Date:  2016-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.